CAR T-Cell Therapy

>

Latest News

CAR T Offers Hope for Challenging Gliomas
CAR T Offers Hope for Challenging Gliomas

March 25th 2024

A novel CAR T-cell therapy being developed at City of Hope offers a potential new treatment avenue for patients with recurrent glioblastoma and high-grade glioma. 

FDA’s ODAC Votes Benefits of Ide-Cel Outweigh Risks in R/R Multiple Myeloma
FDA’s ODAC Votes Benefits of Ide-Cel Outweigh Risks in R/R Multiple Myeloma

March 15th 2024

When CAR T Fails in Myeloma, Can Nivolumab Help?
When CAR T Fails in Myeloma, Can Nivolumab Help?

March 13th 2024

CAR T Cell’s Promise: “[A] single infusion may... keep that cancer in remission.”
CAR T Cell’s Promise: “[A] single infusion may... keep that cancer in remission.”

March 12th 2024

FDA Grants Orphan Drug Designation to Novel CAR T-Cell Therapy in Colorectal Cancer
FDA Grants Orphan Drug Designation to Novel CAR T-Cell Therapy in Colorectal Cancer

March 4th 2024

Video Series
Video Interviews

More News